B12 Absorption: How It Works and What Impairs It

Vitamin B12 absorption depends on an elaborate relay of proteins, enzymes, and receptors that stretches from the stomach to the last stretch of the small intestine. Unlike most nutrients, which simply diffuse across the gut wall, B12 requires a specific escort at every stage, and a breakdown at any single handoff point can leave you deficient even if your diet is rich in the vitamin. That chain of dependencies is what makes B12 deficiency so common and so easy to miss.

The Stomach Sets the Stage

B12 in food is bound tightly to protein. To free it, your stomach needs two things: hydrochloric acid to lower the pH, and pepsin to chop through the protein. Once released, B12 doesn’t float around unattached for long. It immediately latches onto a transport protein called haptocorrin (sometimes called R protein), which is secreted in saliva and gastric juice. Haptocorrin acts as a protective chaperone, shielding B12 from the harsh acid environment as the mixture moves toward the small intestine.¹

This first step is deceptively important. Anything that raises stomach pH or reduces pepsin activity threatens B12 absorption before the vitamin even reaches the intestine. The stomach’s role is often described as “releasing” B12, but it is really two jobs: liberating the vitamin from food and packaging it with a bodyguard for the trip ahead.

The Handoff in the Small Intestine

When the stomach empties into the upper small intestine, a critical swap has to happen. Haptocorrin is a good short-term carrier, but it cannot deliver B12 to the cells that absorb it. That job belongs to intrinsic factor, a protein produced by the parietal cells of the stomach. For B12 to move from haptocorrin to intrinsic factor, pancreatic enzymes have to partially break down haptocorrin first. In lab studies, pancreatic proteases accomplish this transfer within about ten minutes.²

In healthy people, essentially all the B12 ends up attached to intrinsic factor after this step. But in people with exocrine pancreatic dysfunction, more than 60% of B12 stays stuck on haptocorrin because there aren’t enough pancreatic enzymes to break it down. That haptocorrin-bound B12 cannot be absorbed, and it passes straight through the gut.³

Absorption in the Terminal Ileum

The intrinsic factor–B12 complex travels the length of the small intestine until it reaches the terminal ileum, the last segment before the large intestine. Here, a receptor called cubam sits on the surface of the intestinal lining and grabs the complex. Cubam is made of two proteins, cubilin and amnionless, and it pulls the whole package inside the cell through a process called receptor-mediated endocytosis.⁴

This is the only spot in the gut where active B12 absorption happens. The ileum has a limited number of cubam receptors, and they can only process so much B12 at once. That saturation effect is why the percentage of B12 you absorb drops sharply as the dose goes up. From a small dose of about 3 micrograms (roughly what you’d get from a serving of meat), absorption can reach around 80%. From a large dose like the 38 micrograms found in a portion of liver, absorption falls to under 5%.⁵ This is the reason that megadose B12 supplements (1,000 micrograms or more) still deliver some B12 even in people with impaired intrinsic factor: a tiny percentage of a very large dose, absorbed passively, can be enough to prevent frank deficiency.

Into the Bloodstream and Cells

Once inside the ileal cell, B12 is stripped from intrinsic factor and released into the blood, where it meets a new carrier called transcobalamin. Only B12 bound to transcobalamin (called holotranscobalamin, or holoTC) is actually available for delivery to cells. Transcobalamin is secreted by the vascular endothelium, has a short half-life, and binds B12 tightly.⁶ Your cells pick it up through yet another specific receptor, CD320, which only recognizes transcobalamin when it is carrying B12.⁷

Most of the B12 in your blood is actually bound to haptocorrin, not transcobalamin. This haptocorrin-bound fraction (called holohaptocorrin) circulates for longer but isn’t readily available to tissues. That’s why measuring holoTC is a better early marker of B12 status than measuring total serum B12, which lumps both fractions together. In studies of older adults, holoTC outperformed total serum B12 and the metabolic marker methylmalonic acid (MMA) as a predictor of true tissue deficiency.⁸

Why the Body’s Reserves Last So Long

Your liver stores somewhere between 1 and 5 milligrams of B12, a remarkably large reserve relative to daily needs. The body also recycles B12 through a loop between the liver and the gut: the liver secretes B12 into bile, and the ileum reabsorbs most of it. This enterohepatic circulation means that even after absorption completely stops, it can take years for deficiency to develop. A pooled analysis of studies found that roughly 0.13% of total body stores are lost per day, which translates to a depletion timeline of several years if intake drops to zero.⁵

This slow depletion is a double-edged sword. On one hand, it provides a generous buffer. On the other, it means that by the time you develop symptoms of B12 deficiency, the underlying cause might have been silently operating for years. In people with pancreatic disease, this recycling loop can itself be disrupted: if haptocorrin degradation isn’t working properly, the B12 secreted in bile gets bound to haptocorrin in the gut and can’t be transferred to intrinsic factor for reabsorption.⁹

Pernicious Anemia and Autoimmune Gastritis

The most well-known cause of B12 malabsorption is pernicious anemia, an autoimmune condition in which the immune system attacks the parietal cells of the stomach. Those cells produce both hydrochloric acid and intrinsic factor, so their destruction removes both the acid needed to free B12 from food and the protein needed to escort it to the ileum. On top of that, many patients also develop antibodies that directly neutralize any intrinsic factor that is still produced.¹⁰

Diagnosis can be tricky. Anti-parietal cell antibodies show up in about 90% of pernicious anemia patients but aren’t very specific: they also appear in people with non-autoimmune stomach inflammation and other autoimmune conditions. Anti-intrinsic factor antibodies are much more specific to pernicious anemia but are only found in about 60% of patients, so a negative test doesn’t rule it out.¹¹ This is one reason the condition is sometimes diagnosed only after neurological symptoms have already appeared.

Acid-Suppressing Medications

Proton pump inhibitors (PPIs) and H2 blockers are among the most widely prescribed medications in the world, and both reduce stomach acid. Because acid is necessary to release B12 from food proteins, long-term use of these drugs can impair that first step of absorption. The mechanism is straightforward: without enough acid, pepsinogen doesn’t convert to pepsin efficiently, and food-bound B12 stays locked to its protein carrier.¹²

The clinical significance is debated. One small controlled study found that absorption of protein-bound B12 was roughly halved in PPI users compared to non-users, though this impairment could be partially reversed just by consuming an acidic drink alongside the B12 source. Whether this level of malabsorption leads to actual deficiency over time depends on how much B12 someone gets from their diet, how large their stores are, and how long they stay on the medication.¹³ The evidence isn’t strong enough to say everyone on a PPI needs B12 monitoring, but people who have been on these drugs for years, especially if they also eat little meat, probably deserve periodic screening.

Pancreatic Insufficiency

As described in the handoff section, pancreatic enzymes are essential for breaking down haptocorrin so B12 can transfer to intrinsic factor. In chronic pancreatitis, this step fails. Studies of intestinal fluid from patients with chronic pancreatitis show that their gut degrades only about a third of haptocorrin, compared to over 95% in healthy controls. As a result, most of their B12 stays trapped on haptocorrin and can’t be absorbed.⁹

Pancreatic enzyme replacement therapy often improves B12 absorption in these patients, which helps confirm that the problem is enzymatic rather than structural. This is one of the less recognized causes of B12 deficiency and can be overlooked when doctors focus exclusively on intrinsic factor or ileal disease.

Ileal Disease and Surgical Resection

Because the terminal ileum is the only site of active B12 absorption, any disease or surgery affecting that area poses a direct threat. Crohn’s disease frequently involves the terminal ileum, and surgical removal of diseased segments is common. A study of patients with Crohn’s-related ileal resections found that removing more than 60 centimeters of ileum invariably led to B12 malabsorption. But even resections as small as 10 centimeters or less were associated with malabsorption in about 38% of patients.¹⁴

A separate study found that patients who had less than 20 centimeters removed maintained normal absorption, but among those who lost more, about half developed measurable malabsorption with no clear linear relationship between the length of bowel removed and the degree of impairment.¹⁵ The takeaway is that the impact of surgery is somewhat unpredictable: some people compensate better than others, possibly due to variations in where their cubam receptors are concentrated.

Metformin and Calcium-Dependent Absorption

Metformin, the most commonly prescribed drug for type 2 diabetes, has long been associated with lower B12 levels. The mechanism appears to involve calcium. The cubam receptor in the ileum relies on calcium to grab the intrinsic factor–B12 complex, and metformin is known to interfere with calcium-dependent membrane processes. A clinical study found that increasing calcium intake reversed the B12 malabsorption caused by metformin, which supports this mechanism.¹⁶

This finding has a practical implication that many prescribers still don’t act on: people on long-term metformin should have their B12 levels checked periodically, and adequate calcium intake may offer some protection. Given how many people worldwide take metformin, even a modest rate of B12 depletion adds up to a significant number of affected individuals.

Small Intestinal Bacterial Overgrowth

In small intestinal bacterial overgrowth (SIBO), an abnormally large population of bacteria colonizes the upper small intestine, where they normally shouldn’t be in high numbers. These bacteria consume B12 before it can reach the ileum for absorption. The competition is direct: studies of bacterial binding affinity for B12 have found that many common gut organisms bind B12 with strength comparable to that of intrinsic factor itself, making it plausible that large bacterial populations can intercept the vitamin in transit.¹⁷

SIBO-related B12 deficiency is distinct from most other causes in that it involves consumption of the vitamin, not failure to process or transport it. This means correcting SIBO itself, typically with antibiotics, can restore B12 status without the need for lifelong supplementation.¹⁸

Nitrous Oxide and Functional Inactivation

Nitrous oxide stands apart from the other causes on this list because it doesn’t impair B12 absorption at all. Instead, it destroys B12’s ability to function after it has already been absorbed and delivered to cells. Nitrous oxide oxidizes the cobalt atom at the center of the vitamin, irreversibly inactivating the enzyme methionine synthase, which depends on B12 as a cofactor.¹⁹

For someone with normal B12 stores, brief exposure during a dental procedure is unlikely to cause harm. But for someone who is already borderline deficient, even a single exposure can precipitate acute neurological symptoms. There have been documented cases of neurological injury in people with undiagnosed B12 deficiency who received nitrous oxide during surgery, and developmental concerns have been raised about prolonged nitrous oxide use during labor in mothers with low B12 stores.²⁰ Recreational use of nitrous oxide (“whippets”) carries the same risk and has become a well-recognized cause of B12-related neuropathy in young adults.

Rare Genetic Causes

Some people are born with defects in the cubam receptor itself. The condition, called Imerslund-Gräsbeck syndrome (or selective intestinal malabsorption of B12), results from mutations in the genes encoding either cubilin or amnionless, the two components of cubam. It is inherited recessively, meaning a child needs to inherit a defective copy from each parent. Clusters of cases have been identified in Finland, Norway, and parts of the Eastern Mediterranean, likely reflecting founder effects and higher rates of consanguinity in those populations.²¹

Children with this condition typically present with megaloblastic anemia in early childhood and require lifelong B12 supplementation by injection. The condition is considered rare, but it may be underdiagnosed in populations that don’t routinely screen for it.

Oral, Sublingual, and Injection Routes

The traditional treatment for severe B12 malabsorption has been intramuscular injection, which bypasses the gut entirely. But evidence has accumulated that high-dose oral and sublingual B12 can work just as well in many situations, even when the intrinsic factor pathway is compromised. A systematic review and network meta-analysis comparing all three routes found no significant clinical differences in their ability to raise B12 levels or normalize blood counts and homocysteine levels.²²

One large study comparing sublingual to intramuscular B12 actually found that the sublingual group had a greater increase in serum B12 levels.²³ The likely explanation for why oral megadoses work is the passive diffusion pathway mentioned earlier: at very high doses, enough B12 crosses the intestinal wall without needing intrinsic factor. A recent meta-analysis concluded that sublingual and oral routes may be especially practical for long-term management, given that they don’t require clinic visits or needles.²⁴

That said, injections are still preferred for acute neurological symptoms, where speed of repletion matters, and for patients who can’t reliably absorb anything orally, such as those with extensive ileal resection or severe SIBO that hasn’t yet been treated. The choice of route should match the cause: if the problem is just acid suppression or mild intrinsic factor impairment, oral megadoses are usually sufficient; if the ileum is missing or non-functional, injections remain the safer bet.

Why Standard Blood Tests Can Mislead

A standard serum B12 test measures the total amount of B12 in the blood, but most of that is bound to haptocorrin and isn’t readily available to cells. Someone can have a “normal” total serum B12 level while their tissue-available B12 is dangerously low. In a study of older adults, holotranscobalamin was a significantly better predictor of functional deficiency than either total serum B12 or methylmalonic acid, with an area under the ROC curve of 0.90 compared to 0.80 for serum B12.⁸

Despite this, holotranscobalamin testing isn’t widely ordered in routine practice. Many clinicians still rely on total B12, which can falsely reassure in cases where haptocorrin levels are high (as in liver disease or some blood cancers) or where early depletion of the active fraction hasn’t yet pulled total levels below the lab’s reference range. If you suspect B12 deficiency but total B12 comes back normal, asking for holotranscobalamin or MMA can clarify the picture. Elevated MMA in the absence of kidney disease is a strong signal that cells are running short of B12, regardless of what the total serum number says.

1
Tidsskrift for den norske legeforening. Assessment of cobalamin status
2
The Journal of Clinical Investigation. Effect of Proteolytic Enzymes on the Binding of Cobalamin to R Protein and Intrinsic Factor
3
JCI Insight. Cobalamin malabsorption due to nondegradation of R proteins in the human intestine
4
PubMed Central. AMN directs endocytosis of the intrinsic factor-vitamin B(12) receptor cubam by engaging ARH or Dab2
5
Karger. Systematic Review on Daily Vitamin B12 Losses and Bioavailability for Deriving Recommendations on Vitamin B12 Intake with the Factorial Approach
6
PubMed. Cellular uptake of vitamin B(12): Role and fate of TCblR/CD320, the transcobalamin receptor
7
PubMed Central. Cellular uptake of cobalamin: transcobalamin and the TCblR/CD320 receptor
8
Clinical Chemistry. Diagnostic Accuracy of Holotranscobalamin, Methylmalonic Acid, Serum Cobalamin, and Other Indicators of Tissue Vitamin B12 Status in the Elderly
9
The American Journal of Clinical Nutrition. In vitro and in vivo evidences that the malabsorption of cobalamin is related to its binding on haptocorrin (R binder) in chronic pancreatitis
10
PubMed. Pathophysiology and laboratory diagnosis of pernicious anemia
11
PubMed. Diagnosis and classification of pernicious anemia
12
PubMed. Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor
13
Austin Journal of Nutrition and Metabolism. Malabsorption-Related Issues Associated with Chronic Proton Pump Inhibitor Usage
14
PubMed. Vitamin B12 absorption after ileorectal anastomosis for Crohn’s disease: effect of ileal resection and time span after surgery
15
PubMed. Vitamin B12 malabsorption in patients with limited ileal resection
16
PubMed. Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin
17
JCI Insight. Vitamin B12 uptake by intestinal microorganisms: mechanism and relevance to syndromes of intestinal bacterial overgrowth
18
PubMed Central. Association between Small Intestinal Bacterial Overgrowth and Subclinical Atheromatous Plaques
19
PubMed. Methionine synthase inactivation by nitrous oxide during methionine loading of normal human fibroblasts
20
Journal of Medical – Clinical Research & Reviews. Developmental Delay in Children Due to Inactivation of Methionine Synthase by Nitrous Oxide During Labour
21
PubMed. Genetically heterogeneous selective intestinal malabsorption of vitamin B12: founder effects, consanguinity, and high clinical awareness explain aggregations in Scandinavia and the Middle East
22
PubMed Central. Efficacy of different routes of vitamin B12 supplementation for the treatment of patients with vitamin B12 deficiency: A systematic review and network meta-analysis
23
PubMed. Comparison of sublingual vs. intramuscular administration of vitamin B12 for the treatment of patients with vitamin B12 deficiency
24
PubMed Central. Efficacy of sublingual and oral vitamin B12 versus intramuscular administration: insights from a systematic review and meta-analysis